648 related articles for article (PubMed ID: 16678396)
1. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
2. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
[TBL] [Abstract][Full Text] [Related]
3. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
[TBL] [Abstract][Full Text] [Related]
4. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
[TBL] [Abstract][Full Text] [Related]
5. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
Micheletto C; Tognella S; Guerriero M; Dal Negro R
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma.
Micheletto C; Visconti M; Trevisan F; Tognella S; Bertacco S; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2010 Jun; 42(3):120-4. PubMed ID: 20648775
[TBL] [Abstract][Full Text] [Related]
7. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
[TBL] [Abstract][Full Text] [Related]
9. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
10. Acoustic rhinometry and aspirin nasal challenge in the diagnosis of aspirin-intolerant asthma: clinical finding and safety aspects.
Muñoz-Cano R; Bartra J; Sanchez-Lopez J; Picado C; Bissinger I; Valero A
Int Arch Allergy Immunol; 2013; 160(3):307-12. PubMed ID: 23095368
[TBL] [Abstract][Full Text] [Related]
11. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma.
Nasser SM; Patel M; Bell GS; Lee TH
Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of urinary leukotriene E4 levels in asymptomatic bronchial asthma].
Yamamoto H; Kuramitsu K; Houya I; Maruo H; Sakata K; Tabe K; Kimura I; Inoue K; Shibasaki M; Yamamoto K; Sakamoto Y; Matsuo H
Arerugi; 1996 Oct; 45(10):1106-11. PubMed ID: 8958657
[TBL] [Abstract][Full Text] [Related]
13. [Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge].
Rubinsztajn R; Wrońska J; Chazan R
Pol Arch Med Wewn; 2003 Aug; 110(2):849-54. PubMed ID: 14682223
[TBL] [Abstract][Full Text] [Related]
14. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
[TBL] [Abstract][Full Text] [Related]
15. Urinary leukotriene E4 in bronchial asthma.
Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH
Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055
[TBL] [Abstract][Full Text] [Related]
16. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
[TBL] [Abstract][Full Text] [Related]
17. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
[TBL] [Abstract][Full Text] [Related]
18. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
Kupczyk M; Kurmanowska Z; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
[TBL] [Abstract][Full Text] [Related]
19. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.
Nizankowska E; Bestyńska-Krypel A; Cmiel A; Szczeklik A
Eur Respir J; 2000 May; 15(5):863-9. PubMed ID: 10853850
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
Rolla G; Di Emanuele A; Dutto L; Marsico P; Nebiolo F; Corradi F; Brussino L; Bucca C
Allergy; 2004 Aug; 59(8):827-32. PubMed ID: 15230814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
